# Trading Journal

Append-only log of every trading cycle. Newest entries at the bottom. Written by the
autonomous agent itself each cycle. See `STRATEGY.md` for the entry format.

---

## Cycle 0 — 2026-07-14 (setup)
**Portfolio:** $1,000.00 total | $1,000.00 cash | positions: none
**Realized P&L to date:** $0.00
**Market read:** Experiment initialized. Fresh $1,000 all-cash balance in the Agentic
account (`••••6885`). No positions yet.
**Actions:**
- None (setup only).
**Thesis / notes:** Standing instructions live in `STRATEGY.md`. Mandate: build a
diversified equity basket with ~$50 starting positions, full discretion on selection,
one cycle roughly every 3 days, human fully out of the loop. First real trading cycle
(Cycle 1) follows.

---

## Cycle 1 — 2026-07-14 (Tuesday)
**Portfolio:** $1,000.05 total | $500.00 cash | 10 positions (~$50 each):
VOO, NVDA, MSFT, AMZN, GOOGL, JPM, LLY, XOM, COST, CAT
**Realized P&L to date:** $0.00
**Market read:** Market open (~11:15 ET), broadly calm. SPY ~$751 (+0.25% vs prior
close). Built a diversified core: broad-market ballast (VOO) plus a spread of quality
large-caps across sectors, ~$50 each, keeping half the account ($500) in cash to add
over future cycles (building in gradually reduces timing risk).
**Actions (all $50 market buys, filled):**
- BUY VOO — 0.072406 @ $690.55 — order `6a564b8b-5e51-47ba-ac7b-18f87a501777` — broad S&P 500 core / ballast.
- BUY NVDA — 0.240575 @ $207.84 — order `6a565275-51cd-4fa2-b3af-581ef3c97342` — AI/semiconductor leader (growth).
- BUY MSFT — 0.129463 @ $386.21 — order `6a565277-191d-4436-a5f8-c22fa9b7d5a7` — software/cloud mega-cap.
- BUY AMZN — 0.203566 @ $245.62 — order `6a565279-0448-4bfc-aae1-3e62c209f5cb` — consumer discretionary + cloud.
- BUY GOOGL — 0.139555 @ $358.28 — order `6a56527a-f635-4320-92f0-eac4508b2d70` — search/AI/communication.
- BUY JPM — 0.145582 @ $343.45 — order `6a56527c-0d18-4969-a206-f42591f12798` — financials bellwether.
- BUY LLY — 0.043555 @ $1147.97 — order `6a56527e-0017-4db1-9aca-ac16789d492a` — healthcare/pharma growth.
- BUY XOM — 0.345972 @ $144.52 — order `6a565280-0b94-4134-a339-58a21b8705db` — energy diversifier.
- BUY COST — 0.053982 @ $926.23 — order `6a565282-a57e-4ff5-b86b-fa82abf5be06` — consumer staples/retail quality.
- BUY CAT — 0.053192 @ $939.99 — order `6a565283-0bcd-4d37-aee7-b08e8ad18d8c` — industrials cyclical.
**Thesis / notes:** Starter basket spans 8+ sectors (ETF core + tech/AI, comm, cons.
disc., financials, healthcare, energy, staples, industrials). ~50% cash held as dry
powder to add positions and rebalance over the next cycles per the money-management
rules. (Note: the account's investor-profile KYC gate initially blocked the 2nd+ trade;
resolved by the owner, after which all buys filled.) Next cycle: review fills vs.
market, consider adding 1–2 missing sectors (e.g. utilities/comm-infra) and begin
building toward the 15–20 name target.

---

## Cycle 2 — 2026-07-14 (Tuesday)
**Portfolio:** $999.10 total | $400.00 cash | 12 positions (~$50 each):
VOO, NVDA, MSFT, AMZN, GOOGL, JPM, LLY, XOM, COST, CAT, NEE, LIN
**Realized P&L to date:** $0.00
**Market read:** Market open (~11:41 ET), broadly firm — SPY $751.62 (+0.33% vs prior
close $749.17). Reconciled broker vs. state.json: all 10 Cycle-1 positions filled and
matched, no open orders, no realized P&L yet. Only minor unrealized drift from
intraday moves (LLY -2.5%, JPM +1.7%, NVDA +2.6% since Cycle 1 fills).
**Actions:**
- BUY NEE — $50.00 (0.558472 sh @ $89.53 avg) — order `6a5658a7-4220-4f7a-9a78-0be3f6d1ecd6` — utilities sector was missing; regulated FL utility + renewables leader, 2.7% yield, reasonable PE (~22).
- BUY LIN — $50.00 (0.095154 sh @ $525.46 avg) — order `6a5658a9-fdc3-4ac2-b6bf-c8c3ddfeba30` — materials/industrial-gases sector was missing; wide-moat quality compounder (Linde), steady dividend grower.
**Thesis / notes:** Continuing the deliberate build-out from Cycle 1 (same trading day,
so kept turnover light — 2 new adds, no trims/exits since nothing in the ~1hr since
Cycle 1 broke any thesis). Now 12 names across 10 sectors, cash down to ~40% ($400/$999),
still well above the 5-15% target band — intentional, to keep dry powder for measured
additions rather than deploying all at once. Considered AMT (comm-infra/cell-tower
REIT) but it's ~28% off its 52-week high and near a fresh low — skipping for now,
watching for stabilization. Considered PLD (logistics REIT) but Robinhood's sector
tagging buckets REITs under "Finance" alongside JPM — holding off until sector
attribution is clearer, to avoid understating financials concentration. Next cycle:
keep building toward 15-20 names (real estate, comm-infra, small/mid-cap or
international diversifier candidates remain open); re-check AMT/PLD; monitor LLY's
pullback (-2.5% today, no thesis-breaking news found) and NVDA/JPM strength.

---

## Cycle 3 — 2026-07-16 (Thursday)
**Portfolio:** $1,004.30 total | $400.00 cash (pre-trade) | 12 positions (~$50 each):
VOO, NVDA, MSFT, AMZN, GOOGL, JPM, LLY, XOM, COST, CAT, NEE, LIN
**Realized P&L to date:** $0.00 (confirmed via broker — zero closed trades all-time)
**Market read:** Market open (~11:04 ET). SPY $753.90 (-0.12% vs prior close $754.81),
broadly flat/quiet session. Reconciled broker vs. state.json: all 12 positions,
cash ($400.00), and buying power matched exactly — no discrepancies. No open/resting
orders found. Position weights all ~4.7-5.2% of portfolio (VOO/NVDA/MSFT/AMZN/GOOGL/
JPM/LLY/XOM/COST/CAT/NEE/LIN) — nowhere near the 10-15% single-name ceiling, and no
sector near the 25-30% cap. No thesis breaks identified: CAT is down ~5% from cost
(892.44 vs 939.99 avg) on no specific negative news found, NVDA roughly flat, LLY up
~2.8% since purchase — holding all 12 as-is, no trims/exits this cycle.
**Actions:**
- BUY PLD — $50.00 (0.335296 sh @ $149.12 avg, filled) — order `6a58f30d-a901-46e9-88ea-379b5e06614d` — Prologis, logistics/industrial REIT; clean uptrend off the June 30 low ($135.47) to near 52-wk highs ($149-150 range), fills the still-missing real-estate sector. Note: Robinhood tags PLD "Finance" alongside JPM, but combined weight is only ~10% of portfolio, well under the 25-30% sector cap, so proceeding despite the tagging ambiguity flagged in Cycle 2.
- BUY VXUS — $50.00 (0.593824 sh @ $84.20 avg, filled) — order `6a58f30e-8d98-4813-a16c-15afc346ff38` — Vanguard Total International ex-US ETF; portfolio had zero international exposure, adds broad developed+emerging-market diversification per the diversification mandate.
**Thesis / notes:** Re-checked AMT (comm-infra REIT, on watchlist since Cycle 1):
price has been choppy/basing between ~$162-170 for three weeks, still below its 50-day
SMA (~178) with RSI a neutral 43 — no clear stabilization signal yet, so skipped again
in favor of PLD which has a cleaner uptrend. Now 14 positions across 11 sectors
(added Real Estate, International). Cash ~$300/$1,004 (~30%), still above the 5-15%
target band but continuing the intentional gradual build toward 15-20 names —
expect 1-2 more small/mid-cap or additional diversifier adds over the next couple
cycles before cash normalizes into the target band. Watch next cycle: re-check AMT
for stabilization, monitor CAT's -5% drawdown for any fundamental deterioration
(vs. just noise), consider a dedicated small/mid-cap ETF (e.g. IJR) to round out the
market-cap spectrum.

---

## Cycle 4 — 2026-07-19 (Sunday)
**Portfolio:** $996.05 total | $300.00 cash | 14 positions: VOO -1.1%, NVDA -2.5%,
MSFT +2.0%, AMZN +0.7%, GOOGL -3.3%, JPM -0.7%, LLY +2.7%, XOM +2.0%, COST +1.6%,
CAT -6.4%, NEE -0.8%, LIN -2.4%, PLD +0.4%, VXUS -1.0% (all vs. avg cost)
**Realized P&L to date:** $0.00 (confirmed via broker, all-time, zero closing trades)
**Market read:** Market closed — Sunday, no session since Friday 2026-07-17 close.
SPY closed Friday at $743.18, down -1.0% from Thursday's $750.72, a broad
risk-off pullback (most holdings down slightly; CAT and GOOGL the biggest laggards).
No single-name news found explaining the move — reads as market-wide, not
stock-specific.
**Actions:**
- None. Market closed; dollar-based/fractional orders (the account's standard sizing)
  require regular trading hours, so no new buys were queued. Reconciled broker vs.
  state.json: all 14 positions, cash ($300.00), and buying power ($300.00) matched
  exactly, no open/resting orders, $0 realized P&L — no discrepancies. Deferring to
  the next cycle when the market is open, per STRATEGY.md's discretion on closed-market
  cycles and the minimize-turnover rule.
**Thesis / notes:** No thesis breaks identified — Friday's -1% broad pullback (SPY)
looks like market noise, not company-specific deterioration. CAT is now -6.4% from
cost (was -5% at Cycle 3), the largest laggard and worth a closer fundamentals/news
check next cycle to confirm it's still noise and not a break. GOOGL's -3.3% is new
since Cycle 3 (was near flat) — also worth a quick check next cycle, no specific
negative news found in this pass. Cash still ~30% ($300/$996), above the 5-15% target
band; the build-out toward 15-20 names (AMT re-check, IJR small-cap diversifier) picks
back up next cycle once the market is open for fractional buys.

---

## Cycle 5 — 2026-07-22 (Wednesday)
**Portfolio:** $998.998 total pre-trade | $300.00 cash | 14 positions: VOO -0.37%,
NVDA +1.27%, MSFT +0.87%, AMZN -0.64%, GOOGL -2.71%, JPM +0.95%, LLY +1.35%,
XOM +6.92%, COST -0.38%, CAT -4.63%, NEE -0.54%, LIN -3.46%, PLD -1.03%, VXUS +0.46%
(all vs. avg cost, intraday prices)
**Realized P&L to date:** $0.00 (confirmed via broker, all-time span, zero closing trades)
**Market read:** Market open (~11:08 ET). SPY $748.51, roughly flat vs. Friday's close
(prior session $748.28). Reconciled broker vs. state.json: all 14 positions, cash
($300.00), buying power ($300.00), and $0 realized P&L matched exactly — no
discrepancies, no open/resting orders. No thesis breaks: CAT's -4.6% drawdown checked
against news — Board just raised the dividend 8% (to $1.63/sh) and multiple analysts
lifted price targets (fair value ~$970 vs ~$913 prior) on strong construction/energy/
data-center demand; stock is +64% YTD, today's dip reads as pre-earnings (Aug 4) noise,
not deterioration. LIN's -3.5% also checked — RBC/BofA/Citi all raised price targets
mid-July on tight helium supply (a tailwind for Linde's gas business); Q2 earnings
July 31, no negative catalyst found. Holding both, no trims/exits this cycle.
**Actions:**
- BUY IJR — $50.00 (0.342635 sh @ $145.9276 avg, filled) — order
  `6a60dcec-60fb-473a-9fc1-08edba8259a5` — iShares Core S&P Small-Cap ETF; portfolio
  was entirely large/mega-cap, this fills the small-cap market-cap gap flagged since
  Cycle 3/4. Technically healthy: $145.96 vs. 50-day SMA $141.63, near 52-wk high
  ($149.35, hit July 1), clean uptrend off the Aug-2025 low ($107.09) — not chasing a
  blowoff top.
- Re-checked AMT (comm-infra REIT, watchlist since Cycle 1): still below its 50-day SMA
  ($165.65 vs. $177.28) with RSI 37.5 (down from 43 at Cycle 3) — trend has gotten
  *weaker*, not stabilized. Skipping again; will keep watching but this name is
  looking less attractive each cycle, may drop from watchlist if no turn soon.
**Thesis / notes:** Now 15 positions across 12 sectors/categories (added small-cap
market-cap tier via IJR). Cash ~$249/$999 (~25%), still above the 5-15% target band but
trending down as planned — one measured add this cycle, keeping turnover low per the
minimize-turnover rule since no position needed trimming/exiting. All 14 legacy
positions still within thesis, no single name or sector near the concentration caps
(all individual weights ~4.7-5.4% of portfolio). Watch next cycle: continue monitoring
CAT/LIN into their upcoming earnings (CAT Aug 4, LIN Jul 31) for any real thesis shift
post-print; re-check AMT for a turn (may retire from watchlist if it keeps deteriorating);
continue gradual build toward 15-20 names and the cash target band — 1 more diversifier
add (e.g. a comm-infra/REIT alternative to AMT, or a dividend-quality ETF) would round
out the roster nicely over the next cycle or two.

---

## Cycle 6 — 2026-07-25 (Saturday)
**Portfolio:** $992.97 total | $250.09 cash | 15 positions: VOO -1.66%, NVDA -0.42%,
MSFT -1.16%, AMZN -5.51%, GOOGL -10.75%, JPM +2.82%, LLY +4.21%, XOM +8.59%,
COST +0.98%, CAT -5.44%, NEE +0.28%, LIN -2.48%, PLD -1.01%, VXUS -0.95%,
IJR -0.72% (all vs. avg cost, using Friday 7/24 close)
**Realized P&L to date:** $0.00 (confirmed via broker, all-time span, zero closing trades)
**Market read:** Market closed — Saturday, no session since Friday 2026-07-24 close.
SPY closed Friday $738.85, down from $748.51 at Cycle 5 (Wed 7/22), a ~-1.3% pullback
over the week. Reconciled broker vs. state.json: all 15 positions, cash, and $0
realized P&L matched (cash $250.09 vs. the $249.00 post-trade estimate logged at
Cycle 5 — a $1.09 gap, immaterial, likely a small accrual/rounding). No open/resting
orders.
**Actions:**
- None. Market closed; dollar-based/fractional orders (the account's standard sizing)
  require regular trading hours, so no new buys or trims were placed. Per
  STRATEGY.md's discretion on closed-market cycles and the minimize-turnover rule,
  deferring to the next cycle when the market is open.
**Thesis / notes:** Checked the two largest laggards for a thesis break: GOOGL
(-10.75% from cost) reported Q2 on 7/22 with a strong beat — revenue +24% to $119.8B,
Google Cloud +82% to $24.8B, EPS $9.11 vs. $2.88 consensus — but sold off ~7% after
guiding 2026 capex to $195-205B, pushing free cash flow negative for the first time
ever; shares are now below their 200-day SMA. AMZN (-5.5%) fell on the same
sector-wide AI-capex-jitters rotation (peers' capex hikes, ~$200B 2026 capex plan of
its own reported) plus a new Senate marketplace inquiry, ahead of its own earnings
7/30. Read this as a sector-wide repricing of AI infrastructure spend, not
company-specific deterioration — both companies beat/are executing, not broken
theses — so holding both, no trim. Position sizes remain well within caps (GOOGL
~4.5%, AMZN ~4.8% of portfolio). CAT (-5.44%) and LIN (-2.48%) unchanged from Cycle 5
read (positive catalysts, earnings CAT 8/4). Cash still ~25% ($250/$993), above the
5-15% target band. Watch next cycle: AMZN earnings 7/30 and CAT earnings 8/4 for real
thesis tests; re-check AMT for a turn; resume the gradual build toward 15-20 names
and the cash target band once the market is open for fractional buys.

---

## Cycle 7 — 2026-07-28 (Tuesday)
**Portfolio:** $995.24 total | $244.19 cash (post-trade) | 15 positions: VOO -1.68%,
NVDA -5.63%, MSFT +2.87%, AMZN -6.68%, GOOGL -8.10%, JPM +3.51%, LLY +6.47%,
XOM +7.53%, COST +5.96%, NEE +0.60%, LIN -1.21%, PLD -0.52%, VXUS -1.40%,
IJR -0.23%, SCHD flat (new) (all vs. avg cost, intraday prices)
**Realized P&L to date:** -$5.90 (CAT closed this cycle; $0 realized all prior cycles,
confirmed via broker)
**Market read:** Market open (~11:13 ET). SPY $738.72, roughly flat vs. Monday's close
($739.09). Reconciled broker vs. state.json cleanly before trading: all 15 positions,
$250.09 cash, $0 realized P&L, no open orders — matched exactly, no discrepancies.
**Actions:**
- SELL CAT — 0.053192 sh @ $829.05 avg (filled), full exit — order
  `6a68c706-49c4-4b87-bd75-c11c3a970058` — realized loss -$5.90. Thesis break, not
  noise: position had deteriorated from -5.44% (Cycle 5) to -11.97% from cost in three
  days. Web research found real fundamental cracks ahead of the Aug 4 print — Resource
  Industries operating margin down ~700bps YoY (segment profit -39%), Power & Energy
  margin down 170bps sequentially, full-year tariff/import-compliance cost guided to
  $2.2-2.4B, total sales -4% YoY missing consensus, and an analyst downgrade to Hold
  (from Buy) on 7/27 explicitly cited as pressuring shares ahead of earnings. RSI a
  neutral 40 (not a panic/oversold bounce setup) and stock is ~23% off its June 30
  52-wk high ($1073.46). This is margin/tariff-driven deterioration, not market noise —
  cutting per the "cut losers" rule rather than holding into an increasingly risky
  earnings print.
- BUY SCHD — $50.00 (1.465850 sh @ $34.1099 avg, filled) — order
  `6a68c70f-84df-42f5-8040-94081765471f` — Schwab US Dividend Equity ETF; fills the
  Industrials gap left by the CAT exit with a diversified, quality-first dividend
  compounder instead of another single-name cyclical bet. Trading at a fresh 52-wk
  high ($34.24), 3.27% SEC yield, PE ~17.6x, ~$20M avg daily volume (liquid) — a
  candidate flagged since Cycle 5 as a good round-out name.
- Checked NVDA (-5.63% from cost, worsened from -0.42% at Cycle 6): web research shows
  this is a broad AI-sector pullback (NVDA -18% off its June high, sector-wide
  de-rating amid OpenAI-related headlines), not a company-specific break — 37-analyst
  consensus remains Buy with a $302 average target vs. $196 spot. Holding, no action.
- Re-checked GOOGL (-8.10%, improved from -10.75%) and AMZN (-6.68%, roughly flat vs.
  -5.51%): no new negative catalysts found; AMZN reports Q2 earnings 7/30 (in 2 days) —
  the real test of the Cycle 6 thesis is still ahead. Holding both, no trims.
**Thesis / notes:** Still 15 positions but now 11 sectors (Industrials slot emptied by
the CAT exit; SCHD adds a diversified dividend-ETF sleeve rather than refilling
Industrials with another single cyclical name — will watch for a higher-quality
industrial/cyclical replacement over future cycles, but in no rush). Cash $244.19/
$995.24 (~24.5%), still above the 5-15% target band — continuing the deliberate,
gradual glide down (was ~25.1% pre-trade). No position or sector near the
concentration caps (largest single names ~5.4%, XOM/LLY/COST cluster). Watch next
cycle: AMZN earnings 7/30 (real thesis test), broader AI-sector sentiment for NVDA/
GOOGL, and continue building toward the 15-20 name target / cash normalization —
a genuine higher-quality industrials name (or another sector-filling ETF) is the
next natural add once one screens well.

---

## Cycle 9 — 2026-08-01 (Saturday)
**Portfolio:** $1,005.17 total | $144.27 cash | 17 positions: VOO -0.59%, NVDA -3.38%,
MSFT +20.43%, AMZN +10.57%, GOOGL -0.54%, JPM +2.44%, LLY +0.05%, XOM +7.57%,
COST +2.77%, NEE -2.90%, LIN -8.97%, PLD -3.00%, VXUS +0.46%, IJR -0.32%,
SCHD -1.93%, XLI +0.46%, XLV +0.45% (all vs. avg cost, Friday 7/31 close)
**vs SPY since inception:** portfolio +0.52% | SPY -0.57% (SPY $746.81 vs. inception
$751.07 on 2026-07-14)
**Realized P&L to date:** -$5.90 (CAT, Cycle 7; confirmed via broker, all-time, one
closing trade)
**Lesson from last cycle:** Cycle 8's decision to hold MSFT/AMZN/GOOGL through
earnings and let Friday's post-print rally play out was correct — MSFT closed Friday
+20.4% from cost (up from +16.9% at the Cycle 8 mid-session check) and AMZN closed
+10.6% (from +10.0%), confirming real beats keep compounding through the session
rather than fading; reactive trimming into a beat would have cost money.
**Market read:** Market closed — Saturday, no session since Friday 2026-07-31 close.
SPY closed Friday at $746.81, up from Thursday's $741.69 (+0.69%), a firm session
driven by strong mega-cap earnings (MSFT, AMZN, GOOGL all up sharply). Reconciled
broker vs. state.json: all 17 positions match exactly, cash $144.27 matches, buying
power $144.27, no open/resting orders, realized P&L -$5.90 all-time (one closing
trade, CAT) — no discrepancies. Portfolio total $1,005.17 (vs. $1,000.40 logged
Friday) reflects Friday's continued mega-cap earnings rally into the close.
**Actions:**
- None — market closed (Saturday). Dollar-based/fractional orders require regular
  trading hours per STRATEGY.md; deferring to the next open-market cycle. No thesis
  breaks found on this pass: LIN remains the largest laggard (-8.97% from cost) but
  no new information since Cycle 8's read (guidance-driven multiple compression on a
  still-healthy business, not deteriorating fundamentals) — holding, no trim. NVDA
  (-3.38%) and NEE (-2.90%) are minor, unremarkable drawdowns with no negative
  catalysts found. All other positions flat-to-up. No single name or sector near
  concentration caps (largest position MSFT ~6.0% of portfolio).
**Thesis / notes:** Still 17 positions, cash $144.27/$1,005.17 (~14.4%), inside the
5-15% target band — future adds remain genuinely selective per Cycle 8's note. Two
near-term catalysts flagged last cycle are now imminent: CAT earnings 2026-08-04 (not
held; watchlist re-check only, not a reflexive re-buy) and LLY earnings 2026-08-05
(held, GLP-1 pipeline trajectory is the thing to watch). AMT stays on the watchlist at
$173.41 (Friday close), still below its ~$176-177 50-day SMA as of Cycle 8 — will
re-check technicals once the market reopens before considering a buy. Next
open-market cycle: reassess LLY ahead of its 8/5 print, watch CAT's 8/4 report for
any real stabilization signal (still not a re-buy candidate absent that), and
continue monitoring LIN for a genuine (not just guidance-timing) deterioration signal.

---

## Cycle 8 — 2026-07-31 (Friday)
**Portfolio:** $1,000.40 total | $144.27 cash (post-trade) | 17 positions: VOO -1.20%,
NVDA -4.93%, MSFT +16.87%, AMZN +10.01%, GOOGL -1.68%, JPM +2.96%, LLY -1.19%,
XOM +6.30%, COST +2.26%, NEE -2.38%, LIN -9.37%, PLD -3.56%, VXUS +0.46%, IJR -0.62%,
SCHD -2.45%, XLI 0.00% (new), XLV 0.00% (new) (all vs. avg cost, intraday prices)
**vs SPY since inception:** portfolio +0.04% | SPY -1.17% (SPY $742.25 vs. inception
$751.07 on 2026-07-14)
**Realized P&L to date:** -$5.90 (CAT, Cycle 7; confirmed via broker, all-time, one
closing trade)
**Lesson from last cycle:** Cycle 7 correctly held NVDA/GOOGL/AMZN through the
AI-capex-jitters sell-off on the read that beats + execution outweigh sector-wide
repricing fear — vindicated this cycle by AMZN's post-earnings +14.7% pop and GOOGL's
+3% AI-optimism rally. Reflexively trimming winners-turned-laggards would have been
the wrong call; research-based conviction was the edge.
**Market read:** Market open (~11:10 ET). SPY $742.25, roughly flat vs. Thursday's
close ($741.69). Reconciled broker vs. state.json: 15 positions, cash $244.27 (vs.
$244.19 logged — $0.08 immaterial drift), $0 open orders, -$5.90 realized P&L
all-time — all matched cleanly, no real discrepancies. Two big overnight moves
investigated: AMZN +14.7% on a Q2 blowout (AWS +37% — fastest pace in 18 quarters,
revenue/EPS crushed estimates) confirming the Cycle 6/7 thesis that AI-capex jitters
were sentiment, not substance; LIN -9.4% from cost (was -1.2% at Cycle 7) despite
*beating* Q2 estimates ($4.50 adj. EPS vs. $4.49 est., revenue beat) — the drop is
guidance-driven multiple compression (Q3/FY26 guide of $4.45-4.55 landed slightly
below the $4.59 consensus), not a broken business (29.5% adj. operating margin, sales
+9%); reading this as noise on a premium multiple, not deterioration. XOM also
reported Q2 this morning: EPS $3.52 missed the $3.68-3.76 estimate range by ~2.7%,
but revenue beat (+42% YoY to $116B) with strong FCF ($17.2B) and $9.4B of shareholder
returns — a modest, explainable miss, not a thesis break. No exits this cycle.
**Actions:**
- BUY XLI — $50.00 (0.279376 sh @ $178.9699 avg, filled) — order
  `6a6cbafe-e952-43de-bb9a-4090209be294` — Industrial Select Sector SPDR ETF; refills
  the Industrials slot left empty since the Cycle 7 CAT exit with diversified quality
  exposure instead of a single cyclical name (the exact lesson from the CAT round-trip).
  Basing right at its 50-day SMA ($178.22 vs. $179.03 spot), neutral RSI 46 — not
  chasing, not broken. Spread ~0.02%, liquid. Score: quality 4, valuation 3, trend 4,
  catalyst 3, fit 5 = 19/25.
- BUY XLV — $50.00 (0.308966 sh @ $161.8299 avg, filled) — order
  `6a6cbaff-85d8-45bf-a2b8-c5f86e9bdd89` — Health Care Select Sector SPDR ETF;
  diversifies healthcare exposure beyond the single-name LLY concentration (portfolio's
  only prior healthcare holding). Healthy uptrend (price $161.75 vs. 50-day SMA
  $156.02), RSI 57 (not overbought), near 52-wk highs without being extended. Spread
  ~0.01%, liquid. Score: quality 5, valuation 4, trend 4, catalyst 3, fit 5 = 21/25.
- Re-checked AMT (comm-infra REIT, watchlist since Cycle 1): RSI improved to 54.6 (from
  37.5 at Cycle 5) but price ($172.47) still below its 50-day SMA ($176.57) — momentum
  is turning but hasn't confirmed a break above the average yet. Keeping on watchlist
  one more cycle rather than buying or dropping; will act on a decisive move above the
  50-day SMA.
- Completed the STRATEGY.md-mandated migration: every holding now has an explicit
  invalidation trigger and next-earnings date recorded in `state.json` (see that file).
**Thesis / notes:** Now 17 positions across 12+ sector slots (Industrials refilled via
XLI, Healthcare diversified via XLV) — within the 15-20 target range for the first
time. Cash $144.27/$1,000.40 (~14.4%) — now inside the 5-15% target band for the first
time since the build-out began; future cycles should be genuinely selective adds only,
not routine glide-down buys. No position or sector near concentration caps (largest
single name MSFT ~5.8%, JPM+PLD "Finance"-tagged combined ~10.0%). Watch next cycle:
LLY earnings 2026-08-05 (5 days out) and CAT earnings 2026-08-04 (watchlist re-check
post-print, still not a reflexive re-buy per Cycle 7's exit reasoning) are the two
near-term catalysts; keep tracking LIN's guide-vs-consensus gap for signs of real
(not just multiple-driven) deceleration; re-check AMT for a confirmed break above its
50-day SMA before considering a buy.

---

## Cycle 10 — 2026-08-04 (Tuesday)
**Portfolio:** $1,018.77 total | $144.27 cash (14.2%) | 17 positions: VOO +2.05%,
NVDA +0.97%, MSFT +28.51%, AMZN +12.78%, GOOGL +5.25%, JPM +5.25%, LLY -1.95%,
XOM +6.13%, COST +1.73%, NEE -3.80%, LIN -8.20%, PLD -5.57%, VXUS +2.25%, IJR +2.34%,
SCHD -1.61%, XLI +3.20%, XLV -0.19% (all vs. avg cost, intraday prices)
**vs SPY since inception:** portfolio +1.88% | SPY +2.07% (SPY $766.62 vs. inception
$751.07 on 2026-07-14)
**Realized P&L to date:** -$5.90 (CAT, Cycle 7; confirmed via broker, all-time, one
closing trade)
**Lesson from last cycle:** Cycle 9's hold-everything call (market closed) cost
nothing — the account gained further into today's open on continued mega-cap
strength, confirming that deferring trades on closed-market cycles rather than
forcing action is the correct default when nothing is broken.
**Market read:** Market open (~11:10 ET). SPY $766.62, +1.2% vs. Monday's close
($757.67) — a firm, broadly risk-on session. Reconciled broker vs. state.json: all 17
positions, $144.27 cash, $144.27 buying power, -$5.90 realized P&L all-time — matched
exactly, no discrepancies, no open/resting orders. Biggest single-name mover in the
market: CAT (not held) reported Q2 pre-market — EPS $8.17 vs. $6.17 est. (+32% beat),
record $20.5B quarterly revenue, operating margin 20.9% (+360bps YoY), record $72B
backlog on data-center-equipment demand — shares opened +11%, now +5.7% on the day
after fading off the open. This is a genuine reversal of the Cycle 7 exit thesis
(margin compression/tariff drag) — but per the execution rule against chasing >5%
intraday spikes, and with CAT's PE now ~40.5x (rich vs. history), not re-buying today;
watching for the move to consolidate before reconsidering. Checked the two largest
laggards for thesis breaks: LIN (-8.2% from cost) — confirmed via broker earnings data
the 7/31 print was a real beat (EPS $4.50 vs $4.48 est.) with a record $8.1B backlog
(+$1B of new electronics wins); Bernstein raised its PT to $564 post-dip calling it a
buying opportunity. Fundamentals intact, but technicals argue against adding now:
price $482 is ~6% below its 50-day SMA ($514) and RSI is 31.2 — a confirmed downtrend,
not a basing/turning setup (scored trend 1/5, see below). PLD (-5.6%) announced a
recommended $18.8B acquisition of UK's SEGRO plc (47% European footprint expansion,
~neutral-to-minimally-dilutive to FFO, closes H1 2027) alongside a $2.1B/15M-share
stock offering pricing 8/5 — the offering is pressuring shares near-term (dilution),
but this is a strategic growth move, not deteriorating logistics demand; invalidation
trigger (occupancy/rent rollover) has not fired. Holding both, no trims.
**Actions:**
- No trades — cash is within the 5-15% target band (14.2%), no existing holding's
  invalidation trigger fired, and the two candidates reviewed (CAT re-buy, LIN add)
  both failed the process: CAT would be chasing a same-day >5% spike into a rich
  ~40.5x PE; LIN scored 16/25 (quality 5, valuation 3, trend 1 — confirmed downtrend
  below its 50-day SMA, catalyst 3, fit 4) and a trend score of 1 disqualifies a buy
  regardless of total per STRATEGY.md. AMT re-checked: still below its 50-day SMA
  ($173.63 vs. $176.16) — no buy signal, stays on watchlist.
**Thesis / notes:** Still 17 positions, cash $144.27/$1,018.77 (~14.2%, inside target
band) — portfolio +1.88% since inception vs. SPY +2.07%, essentially tracking the
index with slight lag, not a drawdown situation. No position or sector near
concentration caps (largest single name MSFT ~6.3%). Watch next cycle: LLY earnings
2026-08-05 (tomorrow, held — GLP-1 pipeline trajectory is the test); CAT for
consolidation after today's spike (a legitimate re-entry candidate once the move
settles, given the reversed margin thesis); LIN for a close above its 50-day SMA
before considering adding to the existing position; PLD's SEGRO deal and 8/5 stock
offering for any sign of investor pushback beyond the immediate dilution reaction.

---
